
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Heart transplantation risk factors
Introduction
Overview
Overview
There are no established risk factors that lead to cardiac transplantation. The prognosis of the patient post-transplantation depends on various donor and recipient factors.
Risk Factors
Risk Factors
Risk factors for poor outcome post-transplantation can be due to donor-specific characteristics, recipient-specific characteristics, and risk factors due to interactions between the donor and recipient.
Common risk factors
Donor factors
Both the following factors are associated with an increased one-year mortality rate in the recipient.
Recipient factors
- Use of total artificial heart as a bridge to transplant or a need for end-organ support in the form of mechanical ventilation or dialysis– associated with the greatest one-year mortality
- Best prognosis is seen if the indication for transplant is ischemic and nonischemic cardiomyopathy [2]
- Patients with a history of congenital heart disease, restrictive cardiomyopathy, and those undergoing retransplantation have a worse prognosis.
- Younger recipients (below age 55) have an advantage
- Pre-transplant serum creatinine and total bilirubin are linearly related to survival.
Less common risk factors
- Use of Amiodarone pretransplantation [3]
- Hypertension
- Hypercholesterolemia [4] [5]
- Diabetes
- Renal insufficiency
- Use of specific immunosuppressive regimen
- Elevated body mass index
- Tobacco use
- Obesity
- Early post-transplant complications
- Prior cardiac surgery
- Transplantation of a female heart into a male or female recipient [6]
References
References
- β Potapov, Evgenij V.; Loebe, Matthias; H??bler, Michael; Musci, Michele; Hummel, Manfred; Weng, Yu-guo; Hetzer, Roland (1999). “MEDIUM-TERM RESULTS OF HEART TRANSPLANTATION USING DONORS OVER 63 YEARS OF AGE1”. Transplantation. 68 (12): 1834β1838. doi:10.1097/00007890-199912270-00002. ISSNΒ 0041-1337.
- β Khush, Kiran K.; Cherikh, Wida S.; Chambers, Daniel C.; Goldfarb, Samuel; Hayes, Don; Kucheryavaya, Anna Y.; Levvey, Bronwyn J.; Meiser, Bruno; Rossano, Joseph W.; Stehlik, Josef (2018). “The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Reportβ2018; Focus Theme: Multiorgan Transplantation”. The Journal of Heart and Lung Transplantation. 37 (10): 1155β1168. doi:10.1016/j.healun.2018.07.022. ISSNΒ 1053-2498.
- β Cooper LB, Mentz RJ, Edwards LB, Wilk AR, Rogers JG, Patel CB; et al. (2017). “Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality”. J Heart Lung Transplant. 36 (2): 202β210. doi:10.1016/j.healun.2016.07.009. PMCΒ 5241253. PMIDΒ 27520780.
- β Singh TP, Almond CS, Semigran MJ, Piercey G, Gauvreau K (2012). “Risk prediction for early in-hospital mortality following heart transplantation in the United States”. Circ Heart Fail. 5 (2): 259β66. doi:10.1161/CIRCHEARTFAILURE.111.965996. PMIDΒ 22308287.
- β Radovancevic B, Poindexter S, Birovljev S, Velebit V, McAllister HA, Duncan JM; et al. (1990). “Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients”. Eur J Cardiothorac Surg. 4 (6): 309β12, discussion 313. doi:10.1016/1010-7940(90)90207-g. PMIDΒ 2361019.
- β Prendergast TW, Furukawa S, Beyer AJ, Browne BJ, Eisen HJ, Jeevanandam V (1998). “The role of gender in heart transplantation”. Ann Thorac Surg. 65 (1): 88β94. doi:10.1016/s0003-4975(97)01105-3. PMIDΒ 9456101.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
